142 related articles for article (PubMed ID: 16420764)
1. [A study on vasculogenic mimicry in hepatocellular carcinoma].
Zhao XL; Du J; Zhang SW; Liu YX; Wang X; Sun BC
Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):41-4. PubMed ID: 16420764
[TBL] [Abstract][Full Text] [Related]
2. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma.
Sun B; Zhang S; Zhang D; Du J; Guo H; Zhao X; Zhang W; Hao X
Oncol Rep; 2006 Oct; 16(4):693-8. PubMed ID: 16969481
[TBL] [Abstract][Full Text] [Related]
3. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.
Yang SF; Wang SN; Wu CF; Yeh YT; Chai CY; Chunag SC; Sheen MC; Lee KT
J Clin Pathol; 2007 Jun; 60(6):642-8. PubMed ID: 16901975
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
[TBL] [Abstract][Full Text] [Related]
5. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.
Sun B; Qie S; Zhang S; Sun T; Zhao X; Gao S; Ni C; Wang X; Liu Y; Zhang L
Hum Pathol; 2008 Mar; 39(3):444-51. PubMed ID: 18261629
[TBL] [Abstract][Full Text] [Related]
6. Role of angiogenesis in hepatitis and hepatocellular carcinoma.
Ker CG; Chen HY; Juan CC; Lo HW; Shen YY; Chen JS; Lee KT; Sheen PC
Hepatogastroenterology; 1999; 46(26):646-50. PubMed ID: 10370590
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
[TBL] [Abstract][Full Text] [Related]
8. [Three-dimensional cell culture and histology of vasculogenic mimicry in hepatocellular carcinoma].
Zhao J; Huang JS; Yang AJ; Wang CY; Liu W; Li M
Ai Zheng; 2007 Feb; 26(2):123-6. PubMed ID: 17298738
[TBL] [Abstract][Full Text] [Related]
9. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
[TBL] [Abstract][Full Text] [Related]
10. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
11. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
[TBL] [Abstract][Full Text] [Related]
13. Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion.
Jue C; Zhifeng W; Zhisheng Z; Lin C; Yayun Q; Feng J; Hao G; Shintaro I; Hisamitsu T; Shiyu G; Yanqing L
Oncotarget; 2016 Nov; 7(47):77987-77997. PubMed ID: 27793002
[TBL] [Abstract][Full Text] [Related]
14. Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters.
Tsai WC; Chao YC; Lee WH; Chen A; Sheu LF; Jin JS
Histopathology; 2006 Oct; 49(4):388-95. PubMed ID: 16978202
[TBL] [Abstract][Full Text] [Related]
15. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
16. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
18. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.
Shao B; Zhao X; Liu T; Zhang Y; Sun R; Dong X; Liu F; Zhao N; Zhang D; Wu L; Wang Y; Wang M; Meng J; Lin X; Sun B
J Cell Mol Med; 2019 Feb; 23(2):1363-1374. PubMed ID: 30506621
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of different clinical staging systems for hepatocellular carcinoma].
Qu Q; Rui JA; Wang SB; Chen SG; Zhou L; Han K; Wei X; Zhang N; Zhao HT; Cheng EC
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):155-8. PubMed ID: 16750027
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma].
Gao Y; Zhao XL; Gu Q; Wang JY; Zhang SW; Zhang DF; Wang XH; Zhao N; Gao YT; Sun BC
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):585-9. PubMed ID: 20079185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
